TipRanks
Immunovant (DE:4YB)
STUTTGART:4YB
Germany Market
4YB
Immunovant
RESEARCH TOOLSreports

Immunovant (4YB) Balance Sheet

0 Followers

Immunovant Balance Sheet

Immunovant's total assets for Q1 2027 were $852.49M, a decrease of -10.92% from the previous quarter. DE:4YB total liabilities were $117.10M for the fiscal quarter, a 12.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Assets
$ 957.57M$ 776.22M$ 666.71M$ 405.84M$ 515.56M
Total Liabilities
$ 104.97M$ 68.78M$ 48.95M$ 43.34M$ 45.74M
Total Equity Gross Minority
$ 852.59M$ 707.45M$ 617.76M$ 362.49M$ 469.82M
Other Metrics
Currency in USD

Immunovant Debt to Assets